InVivoSIM anti-human VEGFR-2 (Ramucirumab Biosimilar)
| Clone | Ramucirumab | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Catalog # | SIM0012 | ||||||||||||
| Category | InVivoSIM™ Biosimilar Antibodies | ||||||||||||
| Price |
|
This non-therapeutic biosimilar antibody uses the same variable regions from the therapeutic antibody Ramucirumab making it ideal for research use. This Ramucirumab biosimilar reacts with human VEGFR-2 (vascular endothelial growth factor receptor 2) also known as CD309, KDR, and Flk-1. VEGFR-2 is a member of the tyrosine protein kinase family. Upon binding to its ligand VEGF, VEGFR-2 pays key roles in vascular development and permeability. VEGFR-2 is expressed on endothelial cells at high levels in adult heart, lung, kidney, brain, and skeletal muscle as well as other tissues at lower levels. Ramucirumab binds to the extracellular domain of VEGFR-2 and blocks the binding of VEGFR ligands VEGF-A, VEGF-C and VEGF-D leading to inhibition of VEGF-mediated tumor angiogenesis.
| Isotype | human IgG1 |
| Recommended Isotype Control(s) | InVivoPlus™ human IgG1 isotype control |
| Recommended Dilution Buffer | InVivoPure™ pH 7.0 Dilution Buffer |
| Immunogen | Human VEGFR2 |
| Reported Applications |
|
| Formulation |
|
| Endotoxin |
|
| Aggregation |
|
| Purity |
|
| Sterility | 0.2 μM filtered |
| Production | Purified from cell culture supernatant |
| Purification | Protein A |
| Molecular Weight | 150 kDa |
| Murine Pathogen Test Results |
|
| Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
하단영역
(ZIP code : 07532) 902, 9F Hanwha bizmetro 1-cha, 551-17 YangcheonRo,
Gayang-dong, Gangseo-Gu, Seoul, Korea
TEL : 02-2013-8240
FAX : 02-2013-8243
Email : bioxcell@bioxcell.co.kr
Copyright by 2020 BioXCell Korea. All Rights Reserved.
- BioXCell Korea
- Opening hours
- Monday - Friday 9AM - 6PM
- Follow Us
-
